Evidence map›Paper›PMID 41807349›Full record

ReviewCell death discovery2026

Targeting cell death in Crohn's disease: from mechanisms to medicines.

Ying Zhang, Yifan Zhou, Junyan Gao, Jiahui Jia, Xuanming Fan, Miao He, Zixuan He, Yu Bai

Abstract readReview
In one paragraph

Review in Cell death discovery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ying Zhang *Department of Gastroenterology, Changhai Hospital, Naval Medical University, Shanghai, China.
Yifan Zhou *Department of Gastroenterology, Changhai Hospital, Naval Medical University, Shanghai, China.
Junyan Gao *Department of Gastroenterology, Changhai Hospital, Naval Medical University, Shanghai, China.
Jiahui JiaDepartment of Gastroenterology, Changhai Hospital, Naval Medical University, Shanghai, China.
Xuanming FanDepartment of Gastroenterology, Changhai Hospital, Naval Medical University, Shanghai, China.
Miao HeDepartment of Pharmacy, Changhai Hospital, Naval Medical University, Shanghai, China. hmgzyx109@163.com.
Zixuan HeDepartment of Gastroenterology, Changhai Hospital, Naval Medical University, Shanghai, China. zixuan931004@163.com.ORCID http://orcid.org/0000-0002-5883-4038
Yu BaiDepartment of Gastroenterology, Changhai Hospital, Naval Medical University, Shanghai, China. md.baiyu@foxmail.com.

Funding

National Natural Science Foundation of China (National Science Foundation of China) 82300641
6 · The paper itself

Abstract

Crohn's disease (CD) is a chronic inflammatory granulomatous disease that can damage the gastrointestinal tract. Existing treatment methods often fail to achieve satisfactory clinical effects. Although the pathogenesis of CD has not been fully elucidated, increasing evidence suggests that programmed cell death plays a key role in disease progression. This article comprehensively reviews 12 different mechanisms of cell death related to the pathogenesis of CD: apoptosis, necroptosis, pyroptosis, parthanatos, ferroptosis, autophagy-dependent cell death, cuproptosis, oxeiptosis, entotic cell death, netotic cell death, lysosome-dependent cell death, and alkaliptosis. On this basis, the article discusses targeted therapeutic strategies to regulate these cell death pathways, with a particular emphasis on their translational potential in clinical applications. Our analysis of existing studies concludes that autophagy, regulated by ATGs, is crucial in CD, and its dysregulation is associated with genetic factors (ATG16L1, IRGM, NOD2) and the mTOR signaling pathway, suggesting that autophagy may serve as a therapeutic target. Apoptosis and pyroptosis mediated by caspases and gasdermin, respectively, as well as ferroptosis and copper death, are all involved in the pathogenesis of CD, highlighting potential therapeutic strategies through the regulation of these pathways and cell death mechanisms (Graphical abstract 1).

Identifiers

PMID41807349
PMCPMC13039358

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.